MedMira’s Multiplo(R) Rapid (TP/HIV) Test Secures the Health Canada’s Approval for Syphilis and HIV
Shots:
- The Health Canada has approved Multiplo Rapid TP/HIV Test (Multiplo TP/HIV), a critical point-of-care device, for HIV and syphilis. The Reveal TP (Syphilis) approval will follow shortly
- The approval was based on a 2020-2022 clinical evaluation in Alberta involving over 1,500 participants. Study depicted that the test was 100% accurate for HIV and over 98% for syphilis
- The Multiplo TP/HIV rapid test detects HIV-1/2 & syphilis antibodies from a single finger prick, providing immediate results. It is easy to use, high-quality & requires no special storage
Ref: Accesswire | Image: MedMira
Related News:- Signati Medical Reports the IDE Trial Completion of Separo Vessel Sealing System for Vasectomy Procedures
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
